TAG:
specialty lab
National Esoteric/Reference Rankings
By Robert Michel | From the Volume VII No. 14 – October 2, 2000 Issue
Little is known about how the marketplace for hospital send-out testing is divided among national laboratory competitors.These rankings mark the second year THE DARK REPORT has attempted to measure the market for hospital esoteric and reference testing. This ranking does not include niche…
Is it Early-90s “Deja Vu” For Today’s Lab Industry?
By Robert Michel | From the Volume VII No. 14 – October 2, 2000 Issue
CEO SUMMARY: Stock prices for laboratory and pathology companies have skyrocketed since the new decade of the 2000s dawned on January 1. Is investor optimism warranted by the opportunities ahead in diagnostic testing? Or will history repeat itself if the continuing evolution of American h…
“October 2, 2000 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VII No. 14 – October 2, 2000 Issue
More clinical laboratories are interested in obtaining ISO-9000 certification. The laboratory divisions of Kaiser Permanente-Southern California and Kaiser Permanente-Northern California are each preparing for an ISO-9000 certification effort. As reported in this iss…
Lab Industry Attracting New Investment Dollars
By Robert Michel | From the Volume VII No. 11 – July 31, 2000 Issue
CEO SUMMARY: Professional investors with access to hundreds of millions of dollars of investment capital are closely scrutinizing the clinical laboratory industry. They are encouraged by the recent financial performance of public laboratory companies. For independent laboratory owners, th…
Several Labs Planning A Public Stock Offering
By Robert Michel | From the Volume VII No. 11 – July 31, 2000 Issue
CEO SUMMARY: During the past six years, no general clinical laboratory company has undergone an initial public stock offering (IPO). That will certainly change during the next 24 months. There are several private lab companies which want to go public. But this business strategy can only s…
Dr. Bruce Friedman Identifies Market Dynamics Driving Evolution of Lab Information Services
By Robert Michel | From the Volume VII No. 11 – July 31, 2000 Issue
CEO SUMMARY: Probably no one is better positioned to identify the evolution of laboratory information services than Bruce Friedman, M.D., Professor of Pathology at the University of Michigan Medical School in Ann Arbor. For almost 20 years, he has hosted the pre-eminent meeting in laborat…
Neurology is Test Focus For Athena Diagnostics
CEO SUMMARY: There are few examples of laboratory companies focused on a single medical specialty,a business model that is expected to become more common in coming years. One such company is Athena Diagnostics. For 12 years, this company has concentrated on providing diagnostic testing fo…
Columbia/HCA’s $745 Mil Settlement Announced
By Robert Michel | From the Volume VII No. 8 – May 30, 2000 Issue
CEO SUMMARY: Although Columbia/HCA will pay the feds $745 million as part of its recent settlement, the facts of “Medicare fraud” are far from convincing. Wall Street Journal analyst Holman W. Jenkins, Jr. makes a strong argument that the government was able to pick on Columb…
Independent California Lab Decides to Exit Business
By Robert Michel | From the Volume VII No. 5 – March 27, 2000 Issue
CEO SUMMARY: Market forces in California continue to put independent laboratories under sustained financial stress. One laboratory owner decided it was an auspicious time to sell his lab. That sale, of POISONLAB to Laboratory Corporation of America, was announced earlier this month. There…
“March 27, 2000 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VII No. 5 – March 27, 2000 Issue
Will lab information system services be a value- added selling point for the national reference labs? Developments at American Medical Laboratories (AML) and Specialty Laboratories would indicate yes. First, AML entered a strategic alliance with Park City Solutions t…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized